Pharma giant Pfizer Inc.(
) on Monday saw its price target boosted by analysts at Goldman
The firm said it now expects PFE shares to reach $20, which
implies a 13% upside to the stock's Friday closing price of
Goldman noted the company should continue to grow through
acquisitions, and reiterated its "Buy" rating.
Pfizer shares were mostly flat in premarket trading Monday.
The Bottom Line
Shares of PFE have a 4.06% dividend yield, based on Friday's
closing stock price of $17.75. The stock has technical support in
the $15-$17 price area. If the shares can firm up, we see overhead
resistance around the $19-$20 price levels. We would remain on the
sidelines for now.
) is not recommended at this time, holding a Dividend.com DARS™
Rating of 3.4 out of 5 stars.
Be sure to visit our complete recommended list of the
Best Dividend Stocks
, as well as a detailed explanation of
our ratings system here